The DOI matches its Crossref record.
Cancer Statistics, 2008
Open accessAbstract
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Incidence and death rates are age-standardized to the 2000 US standard million population. A total of 1,437,180 new cancer cases and 565,650 deaths from cancer are projected to occur in the United States in 2008. Notable trends in cancer incidence and mortality include stabilization of incidence rates for all cancer sites combined in men from 1995 through 2004 and in women from 1999 through 2004 and a continued decrease in the cancer death rate since 1990 in men and since 1991 in women. Overall cancer death rates in 2004 compared with 1990 in men and 1991 in women decreased by 18.4% and 10.5%, respectively, resulting in the avoidance of over a half million deaths from cancer during this time interval. This report also examines cancer incidence, mortality, and survival by site, sex, race/ethnicity, education, geographic area, and calendar year, as well as the proportionate contribution of selected sites to the overall trends. Although much progress has been made in reducing mortality rates, stabilizing incidence rates, and improving survival, cancer still accounts for more deaths than heart disease in persons under age 85 years. Further progress can be accelerated by supporting new discoveries and by applying existing cancer control knowledge across all segments of the population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Items 101–124 of 124
Boylan, K. L., Andersen, J. D., Anderson, L. B., Higgins, L., & Skubitz, A. P. (2010) · Proteome Science · doi:10.1186/1477-5956-8-31 · Cited by 47
Role of chemokines and chemokine receptors in prostate cancer development and progression.
Singh, R. K., Sudhakar, A., & Lokeshwar, B. L. (2010) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000030 · Cited by 45
Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
Harris, R., Beebe, & Alshafie (2012) · Journal of Experimental Pharmacology · doi:10.2147/jep.s23826 · Cited by 43
CHARAKORN, C., RATTANASIRI, S., LERTKHACHONSUK, A., THANAPPRAPASR, D., CHITTITHAWORN, S., & WILAILAK, S. (2011) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/j.1743-7563.2011.01392.x · Cited by 39
Body Image and Quality of Life in Men With Prostate Cancer
Harrington, J. M., & Badger, T. A. (2009) · Cancer Nursing · doi:10.1097/ncc.0b013e3181982d18 · Cited by 37
PKA Activates AMPK Through LKB1 Signaling in Follicular Thyroid Cancer
Kari, S., Vasko, V. V., Priya, S., & Kirschner, L. S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00769 · Cited by 34
Extracellular Matrix Associated Protein CYR61 is Linked to Prostate Cancer Development
D'Antonio, K. B., Toubaji, A., Albadine, R., Mondul, A. M., Platz, E. A., Netto, G. J., & Getzenberg, R. H. (2010) · Journal of Urology · doi:10.1016/j.juro.2009.12.006 · Cited by 34
Time to Progression of Pancreatic Cancer: Evaluation with Multi-Detector Computed Tomography
Ahn, S. J., Choi, S. J., & Kim, H. S. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-016-9876-7 · Cited by 32
Akbari, A., Amanpour, S., Muhammadnejad, S., Ghahremani, M. H., Ghaffari, S. H., Dehpour, A. R., Mobini, G. R., Shidfar, F., Abastabar, M., Khoshzaban, A., et al. (2014) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-22-47 · Cited by 33
Zhang, H.-S., Yan, B., Li, X.-B., Fan, L., Zhang, Y.-F., Wu, G.-H., Li, M., & Fang, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401521 · Cited by 32
Jang, K. M., Kim, S. H., Kim, Y. K., Song, K. D., Lee, S. J., & Choi, D. (2015) · European Journal of Radiology · doi:10.1016/j.ejrad.2015.05.012 · Cited by 31
Assay of glioma cell responses to an anticancer drug in a cell-based microfluidic device
Liu, W., Sun, P., Yang, L., Wang, J., Li, L., & Wang, J. (2010) · Microfluidics and Nanofluidics · doi:10.1007/s10404-010-0584-5 · Cited by 29
Androgen receptor abnormalities in castration-recurrent prostate cancer.
Nacusi, L. P., & Tindall, D. J. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.34 · Cited by 27
Gulley, J. L., Madan, R. A., Tsang, K.-Y., Arlen, P. M., Camphausen, K., Mohebtash, M., Kamrava, M., Schlom, J., & Citrin, D. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.615741 · Cited by 26
Li, Q., Yang, T., Li, D., Ding, F., Bai, G., Wang, W., & Sun, H. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0162 · Cited by 26
Lin, C.-W., Yang, W.-E., Su, C.-W., Lu, H.-J., Su, S.-C., & Yang, S.-F. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.91786 · Cited by 24
MHAIDAT, N. M., ALZOUBI, K. H., AL-AZZAM, S. I., & ALSAAD, A. A. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1763 · Cited by 20
A Prospective Pilot Clinical Trial of “The Work” Meditation Technique for Survivors of Breast Cancer
Lev-ari, S., Zilcha-Mano, S., Rivo, L., Geva, R., & Ron, I. (2013) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2013.07.003 · Cited by 19
Haque, M. E., Khan, F., Chi, L., Gurung, S., Vadevoo, S. M. P., Park, R.-W., Kim, D.-K., Kim, S. K., & Lee, B. (2019) · Cancer Research and Treatment · doi:10.4143/crt.2018.214 · Cited by 18
Cohen, M. S., Al-kasspooles, M. F., Williamson, S. K., Henry, D., Broward, M., & Roby, K. F. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0669-0 · Cited by 17
Schultheis, B., Strumberg, D., Bergmann, L., Graeven, U., Hanauske, A.-R., Lipp, R., Schuette, J., Saito, K., Scigalla, P., & Scheulen, M. E. (2012) · Investigational New Drugs · doi:10.1007/s10637-011-9665-x · Cited by 14
Chung, K.-S., Choi, H.-E., Shin, J.-S., Cho, E.-J., Cho, Y.-W., Choi, J.-H., Baek, N.-I., & Lee, K.-T. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.11.007 · Cited by 14
Kim, H., Ahn, T. S., Kim, C.-J., Bae, S. B., Kim, H. J., Lee, C.-S., Kim, T. H., Im, J., Lee, S. H., Son, M. W., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.6203 · Cited by 8
Kronik hastalıkların Sosyoekonomik Belirleyicileri Üzerine bir Makine Öğrenmesi Analizi
Ekinci, R. (2025) · İzmir İktisat Dergisi · doi:10.24988/ije.1491030 · Cited by 1
Metadata
- Authors
- Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2008-01-28
- Volume
- 58
- Issue
- 2
- Pages
- 71-96
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2043103956
- Cited by
- 10,188
- References
- 0
- FWCI
- 901.01
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2773 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.